ArticleDiscover nano2026
Exploring the green formulation of silver nanoparticles using Houttuynia cordata leaf extract and their potential for lung cancer treatment.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In Chinese traditional medicine, Houttuynia cordata is used as an ethnomedicinal plant that has many therapeutic uses in this age-old healing method. With its antioxidant properties, this medicinal plant plays a crucial role in safeguarding body cells against various potential damages. More recently, silver nanoparticles green-mediated by ethnomedicinal plants have emerged as a promising treatment option for various ailments. We have conducted an examination of the silver nanoparticles produced through green synthesis methods following the green chemistry principles, utilizing the H. cordata leaf aqueous extract to remove the lung cancer cells. Various techniques including FE-SEM, EDX, UV-Vis, FT-IR, and TEM were employed to analyze the green-synthesized Ag NPs. Based on the results of TEM and FE-SEM, the nanoparticles' spherical shape, size range of 10 to 40 nm and average size of 26.55 nm have been verified. Ag NPs produced biologically were evaluated against lung carcinoma (HLC-1, A549, DMS273 and PC-14) cells. The MTT assay demonstrated that the Ag NPs possess remarkable anti-lung cancer properties dose-dependently. The IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.